Understanding in molecular genetics/correlates, pathogenesis, pharmacology, diagnosis and treatment of acquired and genetic neuromuscular diseases
The Journal of Neuromuscular Diseases aims to facilitate progress in understanding the molecular genetics/correlates, pathogenesis, pharmacology, diagnosis and treatment of acquired and genetic neuromuscular diseases (including muscular dystrophy, myasthenia gravis, spinal muscular atrophy, neuropathies, myopathies, myotonias and myositis). The journal publishes research reports, reviews, short communications, letters-to-the-editor, and will consider research that has negative findings. The journal is dedicated to providing an open forum for original research in basic science, translational and clinical research that will improve our fundamental understanding and lead to effective treatments of neuromuscular diseases.
Editors-in-Chief
Carsten G. Bönnemann
National Institute of Neurological
Disorders and Stroke/NIH, Bethesda, USA
Email: [email protected]
Hanns Lochmüller
Institute of Genetic Medicine
Newcastle University, Newcastle upon Tyne,
United Kingdom
Email: [email protected]
To view the full Editorial Board, please visit:
http://www.iospress.nl/journal/journal-of-neuromuscular-diseases/?tab=editorial-board
Voeg deze kaart toe aan uw website;
We gebruiken cookies en andere trackingtechnologieën om uw browse-ervaring op onze website te verbeteren, om u gepersonaliseerde inhoud en gerichte advertenties te laten zien, om ons websiteverkeer te analyseren en om te begrijpen waar onze bezoekers vandaan komen. Privacybeleid